Aptevo Therapeutics reports FY24 EPS ($87.38) vs. ($2,316.83) last year
PremiumThe FlyAptevo Therapeutics reports FY24 EPS ($87.38) vs. ($2,316.83) last year
2M ago
Aptevo Therapeutics Showcases Promising Oncology Drug Pipeline
Premium
Company Announcements
Aptevo Therapeutics Showcases Promising Oncology Drug Pipeline
2M ago
Aptevo Therapeutics trading resumes
Premium
The Fly
Aptevo Therapeutics trading resumes
4M ago
Aptevo Therapeutics announces 1-for-37 reverse stock split
PremiumThe FlyAptevo Therapeutics announces 1-for-37 reverse stock split
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Aptevo Therapeutics highlights potential of portfolio in cancer immunotherapy
Premium
The Fly
Aptevo Therapeutics highlights potential of portfolio in cancer immunotherapy
4M ago
Aptevo Therapeutics price target lowered to $8 from $15 at Roth MKM
PremiumThe FlyAptevo Therapeutics price target lowered to $8 from $15 at Roth MKM
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100